Abstract
Conducting drug discovery efforts in patient- and disease-specific cells can maximize their likelihood of success. In this issue of Cell Stem Cell, Yang et al. (2013) demonstrate the power of lineage-specific cell-based drug screens by identifying a compound that promotes survival of stem-cell-derived ALS mutant motor neurons.
Original language | English (US) |
---|---|
Pages (from-to) | 633-634 |
Number of pages | 2 |
Journal | Cell stem cell |
Volume | 12 |
Issue number | 6 |
DOIs | |
State | Published - Jun 6 2013 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology